Header Logo

Connection

Michael Gold to RNA, Messenger

Back to Details
This is a "connection" page, showing publications Michael Gold has written about RNA, Messenger.
Michael Gold
Connection Strength
0.018
RNA, Messenger
  1. Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. J Clin Oncol. 2010 Mar 01; 28(7):1215-23.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.